Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02069756 · ClinicalTrials.gov registry record
The Duchenne Registry
A clinical trial of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy, sponsored by The Duchenne Registry.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT02069756: Recruiting study of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy, sponsored by The Duchenne Registry.
NCT02069756 is a study of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy that is actively recruiting participants, run by The Duchenne Registry. The registered enrollment target is 10,000 participants, above the 204-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (4802% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02069756, a study of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy, is actively recruiting participants, sponsored by The Duchenne Registry.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Duchenne Registry is an online, patient-report registry for individuals with Duchenne and Becker muscular dystrophy and carrier females. The purpose of the Registry is to connect Duchenne and Becker patients with actively recruiting clinical trials and research studies, and to educate patients and families about Duchenne and Becker care and research. At the same time, The Duchenne Registry is a valuable resource for clinicians and researchers in academia and industry, allowing access to de-identified datasets provided by patients and their families-information that is vital to advances in the care and treatment of Duchenne. The Duchenne Registry is a member of the TREAT-NMD Neuromuscular Network.
Primary Outcome
Genetic variant data is collected by patient report and verified by curation/review of genetic test report when provided. Genetic test report is requested for each registrant and is required for participation in global DMD (TREAT-NMD) registry.
Conditions Studied
Study Locations (1)
District of Columbia
- The Duchenne Registry / PPMD - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2007-10 |
| Est. Completion | 2047-10 |
What NCT02069756 shows while recruiting
NCT02069756 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 204-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (4802% higher).
The record links to 2 conditions, with Duchenne Muscular Dystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT02069756 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02069756 about?
NCT02069756 is a clinical study titled "The Duchenne Registry". The Duchenne Registry is an online, patient-report registry for individuals with Duchenne and Becker muscular dystrophy and carrier females. The purpose of the Registry is to connect Duchenne and Becker patients with actively recruiting clinical trials and research studies, and to educate patients a...
What is the current status of trial NCT02069756?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2007-10. Estimated completion is 2047-10.
What conditions does trial NCT02069756 study?
This clinical trial studies the following conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy.
Who is sponsoring clinical trial NCT02069756?
This trial is sponsored by The Duchenne Registry, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02069756 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Duchenne Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02069756's enrollment target sits among peer trials
10,000 1st of 48 higher than 48 of 48 other Duchenne Muscular Dystrophy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Duchenne Muscular Dystrophy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
RECRUITING · Phase 1
-
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
RECRUITING · Phase 2
-
Once Weekly Infant Corticosteroid Trial for DMD
RECRUITING · Phase 4
-
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia